BioSpace News Archive

Business

Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India- Sizable and growing market opportunity with 120,000+ patients receiving hemodialysis annually –

Rockwell Medical, Inc. announced that it has entered into license and supply agreements with a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd., for the rights to commercialize Triferic in India.

January 14, 2020
·
7 min read
Business

Orgenesis appoints industry veteran Mario Philips to its board of directors

Mario Philips is chief executive officer of PolyNeuroS, a drug company based in France that has developed a diagnostic platform technology for neurodegenerative diseases in combination with a therapy to cure neurodegenerative diseases such as ALS and Parkinson’s.

January 14, 2020
·
4 min read
Cardax, Inc. Announces Reverse Stock Split of Common Stock

Cardax expects that upon the opening of trading on January 15, 2020, its common stock will trade on the OTCQB on a split-adjusted basis under the current symbol “CDXI” and the new CUSIP number 14141D201.

January 14, 2020
·
4 min read
Policy

Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol

Nektar Therapeutics issued a statement following a meeting of the Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee to discuss the New Drug Application for oxycodegol where the Committees did not recommend approval of oxycodegol.

January 14, 2020
·
3 min read